C64
Conditions
Interventions
Group 1: surgical procedure 1: "open surgery"
All patients who undergo “open” surgery due to renal cell carcinoma should be included (retroperitoneal or transperitoneal approach). The data is collecte
Sponsors
Klinik für Urologie, München Klinik Bogenhausen gGmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Histopathological evidence of renal cell carcinoma - Availability of the image data from the cross-sectional imaging (CT or MRI; CD, USB, internal clinic data storage) - Primary operation in the Department of Urology at the Munich Clinic gGmbH - Ability to give consent to participate in the study (for legally cared for patients by the legal carer)
Exclusion criteria
Exclusion criteria: - Known, hereditary or acquired bleeding tendency (participation is possible if there is a medication-related bleeding tendency; the medication will be adjusted according to the recommendation of the initially ordering doctor or the responsible department in the hospital) - Anatomical anomalies such as severe scoliosis or short stature that prevent a standardized approach - Patients with urothelial carcinoma of the upper urinary tract (e.g. renal pelvic carcinoma)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of complications Rate of complications = grade III according to the Clavien-Dindo classification after renal tumor surgery depending on the surgical procedure used (open, laparoscopic and robotically assisted nephrectomies and partial nephrectomies/renal tumor enucleations for renal cell carcinoma) as well as depending on the patient's R.E.N.A.L. score. All data collected within the Munich Clinic such as laboratory results, radiological reports and surgical reports can be found in SAP®. The medical and nursing documentation is paper-based in the patient file. In the case of paper-based documentation, it is digitized and stored in SAP® after discharge of the patient. The endpoints are evaluated and documented either directly when a complication occurs during the inpatient stay by the doctor or a study nurse. After discharge, the study nurse carries out the annual evaluation and update of occuring complications. | — |
Secondary
| Measure | Time frame |
|---|---|
| Survival (overall survival, progression-free survival, recurrence-free survival) The overall duration of the study is intended to be indefinite, but at least five years. An annual evaluation will be carried out. | — |
Countries
Germany
Contacts
Public ContactMaximilian Erlmeier
Klinik für Urologie, München Klinik Bogenhausen
Outcome results
None listed